Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Synthesis and Biological Studies of O3-Aryl Galactosides as Galectin Inhibitors

Kervefors, Gabriella ; Pal, Kumar Bhaskar ; Tolnai, Gergely L. ; Mahanti, Mukul LU ; Leffler, Hakon LU ; Nilsson, Ulf J. LU and Olofsson, Berit (2021) In Helvetica Chimica Acta 104(2).
Abstract

β-Galactose derivatives have recently been reported to selectively inhibit galectin-3, and a library of O3-arylated galactosides with varying substitution patterns was designed to study such inhibitions further. The O3-arylated galactosides were synthesized using diaryliodonium salts under mild and transition metal free conditions, providing the target products in moderate to good yields. An O3-trifluoroethylated galactoside was also synthesized using iodonium salt chemistry. Azido-substituted products were subsequently transformed into the corresponding triazoles. After deprotection, a selection of galactoside derivatives were evaluated for inhibitory potencies against galectins-1, 3, 4 N (N-terminal domain), 4 C (C-terminal domain),... (More)

β-Galactose derivatives have recently been reported to selectively inhibit galectin-3, and a library of O3-arylated galactosides with varying substitution patterns was designed to study such inhibitions further. The O3-arylated galactosides were synthesized using diaryliodonium salts under mild and transition metal free conditions, providing the target products in moderate to good yields. An O3-trifluoroethylated galactoside was also synthesized using iodonium salt chemistry. Azido-substituted products were subsequently transformed into the corresponding triazoles. After deprotection, a selection of galactoside derivatives were evaluated for inhibitory potencies against galectins-1, 3, 4 N (N-terminal domain), 4 C (C-terminal domain), 7, 8 N, 8 C, 9 N, and 9 C and one compound with promising affinity and selectivity for both the N- and C-terminal domain of galectin-9 was discovered.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
arylation, carbohydrates, galactosides, galectin inhibitor, hypervalent compounds
in
Helvetica Chimica Acta
volume
104
issue
2
publisher
John Wiley & Sons Inc.
external identifiers
  • scopus:85100454987
ISSN
0018-019X
DOI
10.1002/hlca.202000220
language
English
LU publication?
yes
id
598ce7d9-b4c5-42d0-a1f6-ca17f5d7c28e
date added to LUP
2021-02-19 09:11:07
date last changed
2022-04-27 00:22:18
@article{598ce7d9-b4c5-42d0-a1f6-ca17f5d7c28e,
  abstract     = {{<p>β-Galactose derivatives have recently been reported to selectively inhibit galectin-3, and a library of O3-arylated galactosides with varying substitution patterns was designed to study such inhibitions further. The O3-arylated galactosides were synthesized using diaryliodonium salts under mild and transition metal free conditions, providing the target products in moderate to good yields. An O3-trifluoroethylated galactoside was also synthesized using iodonium salt chemistry. Azido-substituted products were subsequently transformed into the corresponding triazoles. After deprotection, a selection of galactoside derivatives were evaluated for inhibitory potencies against galectins-1, 3, 4 N (N-terminal domain), 4 C (C-terminal domain), 7, 8 N, 8 C, 9 N, and 9 C and one compound with promising affinity and selectivity for both the N- and C-terminal domain of galectin-9 was discovered.</p>}},
  author       = {{Kervefors, Gabriella and Pal, Kumar Bhaskar and Tolnai, Gergely L. and Mahanti, Mukul and Leffler, Hakon and Nilsson, Ulf J. and Olofsson, Berit}},
  issn         = {{0018-019X}},
  keywords     = {{arylation; carbohydrates; galactosides; galectin inhibitor; hypervalent compounds}},
  language     = {{eng}},
  number       = {{2}},
  publisher    = {{John Wiley & Sons Inc.}},
  series       = {{Helvetica Chimica Acta}},
  title        = {{Synthesis and Biological Studies of O3-Aryl Galactosides as Galectin Inhibitors}},
  url          = {{http://dx.doi.org/10.1002/hlca.202000220}},
  doi          = {{10.1002/hlca.202000220}},
  volume       = {{104}},
  year         = {{2021}},
}